Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Different pearl indices in studies of hormonal contraceptives in the United States: impact of study population.

Gerlinger C, Trussell J, Mellinger U, Merz M, Marr J, Bannemerschult R, Schellschmidt I, Endrikat J.

Contraception. 2014 Aug;90(2):142-6. doi: 10.1016/j.contraception.2014.03.018. Epub 2014 Apr 13.

PMID:
24813941
[PubMed - in process]
Free Article
2.

Axillary ultrasound for breast cancer staging: an attempt to identify clinical/histopathological factors impacting diagnostic performance.

Ertan K, Linsler C, di Liberto A, Ong MF, Solomayer E, Endrikat J.

Breast Cancer (Auckl). 2013;7:35-40. doi: 10.4137/BCBCR.S11215. Epub 2013 Mar 6.

PMID:
23515655
[PubMed]
Free PMC Article
3.

Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study.

Endrikat J, Parke S, Trummer D, Serrani M, Duijkers I, Klipping C.

Contraception. 2013 Feb;87(2):227-34. doi: 10.1016/j.contraception.2012.07.008. Epub 2012 Sep 17.

PMID:
22995539
[PubMed - indexed for MEDLINE]
4.

Estimation of menstrual blood loss volume based on menstrual diary and laboratory data.

Schumacher U, Schumacher J, Mellinger U, Gerlinger C, Wienke A, Endrikat J.

BMC Womens Health. 2012 Aug 20;12:24. doi: 10.1186/1472-6874-12-24.

PMID:
22906181
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Postnatal neuro-development of fetuses with absent end-diastolic flow in the umbilical artery and/or fetal descending aorta.

Ertan AK, Tanriverdi HA, Stamm A, Jost W, Endrikat J, Schmidt W.

Arch Gynecol Obstet. 2012 Jun;285(6):1547-52. doi: 10.1007/s00404-011-2191-4. Epub 2012 Jan 4.

PMID:
22215198
[PubMed - indexed for MEDLINE]
6.

Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide.

Endrikat J, Gerlinger C, Richard S, Rosenbaum P, Düsterberg B.

Contraception. 2011 Dec;84(6):549-57. doi: 10.1016/j.contraception.2011.04.009. Epub 2011 Jun 8. Review.

PMID:
22078182
[PubMed - indexed for MEDLINE]
7.

Chromosomal abnormalities in fetuses with ultrasonographically detected neural tube defects.

Kanit H, Özkan AA, Öner SR, Ispahi C, Endrikat JS, Ertan K.

Clin Dysmorphol. 2011 Oct;20(4):190-3. doi: 10.1097/MCD.0b013e328348d99d.

PMID:
21709547
[PubMed - indexed for MEDLINE]
8.

The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia.

Endrikat J, Vilos G, Muysers C, Fortier M, Solomayer E, Lukkari-Lax E.

Arch Gynecol Obstet. 2012 Jan;285(1):117-21. doi: 10.1007/s00404-011-1902-1. Epub 2011 Apr 8.

PMID:
21475963
[PubMed - indexed for MEDLINE]
9.

Pattern recognition in menstrual bleeding diaries by statistical cluster analysis.

Gerlinger C, Wessel J, Kallischnigg G, Endrikat J.

BMC Womens Health. 2009 Jul 16;9:21. doi: 10.1186/1472-6874-9-21.

PMID:
19607665
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.

Endrikat J, Shapiro H, Lukkari-Lax E, Kunz M, Schmidt W, Fortier M.

J Obstet Gynaecol Can. 2009 Apr;31(4):340-7.

PMID:
19497153
[PubMed - indexed for MEDLINE]
11.

Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada.

Endrikat JS, Milchev NP, Kapamadzija A, Georgievska J, Gerlinger C, Schmidt W, Feroze S.

Contraception. 2009 Jun;79(6):428-32. doi: 10.1016/j.contraception.2008.12.007. Epub 2009 Feb 7.

PMID:
19442777
[PubMed - indexed for MEDLINE]
12.

Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.

Endrikat J, Parke S, Trummer D, Schmidt W, Duijkers I, Klipping C.

Contraception. 2008 Sep;78(3):218-25. doi: 10.1016/j.contraception.2008.05.004. Epub 2008 Jul 11.

PMID:
18692612
[PubMed - indexed for MEDLINE]
15.

A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight.

Endrikat J, Sandri M, Gerlinger C, Rübig A, Schmidt W, Fortier M.

Eur J Contracept Reprod Health Care. 2007 Sep;12(3):220-8.

PMID:
17763260
[PubMed - indexed for MEDLINE]
16.

Evaluation of menstrual bleeding patterns: a new proposal for a universal guideline based on the analysis of more than 4500 bleeding diaries.

Gerlinger C, Endrikat J, Kallischnigg G, Wessel J.

Eur J Contracept Reprod Health Care. 2007 Sep;12(3):203-11.

PMID:
17763258
[PubMed - indexed for MEDLINE]
18.

Cyclic menstruation-like bleeding during denied pregnancy. Is there a particular hormonal cause?

Wessel J, Endrikat J.

Gynecol Endocrinol. 2005 Dec;21(6):353-9.

PMID:
16390784
[PubMed - indexed for MEDLINE]
19.

A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.

Jespersen J, Endrikat J, Düsterberg B, Schmidt W, Gerlinger C, Wessel J, Sidelmann JJ, Skouby SO.

Contraception. 2005 Aug;72(2):98-104.

PMID:
16022847
[PubMed - indexed for MEDLINE]
20.

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.

Skouby SO, Endrikat J, Düsterberg B, Schmidt W, Gerlinger C, Wessel J, Goldstein H, Jespersen J.

Contraception. 2005 Feb;71(2):111-7.

PMID:
15707560
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk